Struthers Richard Scott 4
4 · Crinetics Pharmaceuticals, Inc. · Filed Apr 4, 2025
Insider Transaction Report
Form 4
Struthers Richard Scott
DirectorPresident & CEO
Transactions
- Exercise/Conversion
Common Stock
2025-04-02$1.91/sh+81,270$155,226→ 410,417 total - Exercise/Conversion
Stock Option (Right to Buy)
2025-04-02−81,270→ 0 totalExercise: $1.91Exp: 2028-03-16→ Common Stock (81,270 underlying)
Holdings
- 1,000(indirect: By Spouse)
Common Stock
- 110,000(indirect: By Trust)
Common Stock
- 570,805(indirect: By Trust)
Common Stock
- 110,000(indirect: By Trust)
Common Stock
- 100,000(indirect: By Trust)
Common Stock
Footnotes (1)
- [F1]1/48th of the shares subject to the option vested on April 16, 2018, and 1/48th of the shares subject to the option vest monthly thereafter, subject to the Reporting Person's continued employment with the Issuer on each such vesting date.